Identification of autoantigens specific for systemic lupus erythematosus with central nervous system involvement

Lupus

Volumn 19, Issue 6, 2010, Pages 717-726

  Iizuka, N ^a,b   Okamoto, K ^a   Matsushita, R ^b   Kimura, M ^b   Nagai, K ^a   Arito, M ^a   Kurokawa, M S ^a   Masuko, K ^a   Suematsu, N ^a   Hirohata, S ^b   Kato, T ^a  

^a ST MARIANNA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti neuronal cell antibodies; Autoantigen; CNS Lupus; Proteomics; Western blot

Indexed keywords

AUTOANTIGEN; CELL ANTIBODY; HISTONE H2A; ISOENZYME; PEROXIREDOXIN 4; UBIQUITIN THIOLESTERASE;

ADULT; ANTIGEN DETECTION; ARTICLE; CELL CULTURE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NEUROBLASTOMA CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; SYSTEMIC LUPUS ERYTHEMATOSUS; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

ADULT; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HISTONES; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; MIDDLE AGED; NEUROBLASTOMA; PEROXIREDOXINS; RNA-BINDING PROTEINS; UBIQUITIN THIOLESTERASE; YOUNG ADULT;

EID: 77951220867     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309357764     Document Type: Article

References (52)

1. Sherer Y., Gorstein A., Fritzler MJ, Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 2004 ; 34: 501-537. (Pubitemid 40288129)
2. Shoenfeld Y., Twig G., Katz U., Sherer Y. Autoantibody explosion in antiphospholipid syndrome. J Autoimmun 2008 ; 30: 74-83.
3. Bluestein HG Neuropsychiatric manifestations of systemic lupus erythematosus. N Engl J Med 1987 ; 317: 309-311. (Pubitemid 17100111)
4. Hanly JG, McCurdy G., Fougere L., Douglas JA, Thompson K. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol 2004 ; 31: 2156-2162. (Pubitemid 39453234)
5. Harris EN, Hughes GR Cerebral disease in systemic lupus erythematosus. Springer Semin Immunopathol 1985 ; 8: 251-266. (Pubitemid 15225656)
6. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999 ; 42: 599-608.
7. Senecal JL, Raymond Y. The pathogenesis of neuropsychiatric manifestations in systemic lupus erythematosus: a disease in search of autoantibodies, or autoantibodies in search of a disease? J Rheumatol 2004 ; 31: 2093-2098. (Pubitemid 39453223)
8. Hanly JG Evaluation of patients with CNS involvement in SLE. Baillieres Clin Rheumatol 1998 ; 12: 415-431.
9. Castellino G., Govoni M., Giacuzzo S., Trotta F. Optimizing clinical monitoring of central nervous system involvement in SLE. Autoimmun Rev 2008 ; 7: 297-304.
10. Wilson HA, Winfield JB, Lahita RG, Koffler D. Association of IgG anti-brain antibodies with central nervous system dysfunction in systemic lupus erythematosus. Arthritis Rheum 1979 ; 22: 458-462. (Pubitemid 10146141)
11. Long AA, Denburg SD, Carbotte RM, Singal DP, Denburg JA Serum lymphocytotoxic antibodies and neurocognitive function in systemic lupus erythematosus. Ann Rheum Dis 1990 ; 49: 249-253. (Pubitemid 20140751)
12. Bresnihan B., Oliver M., Williams B., Hughes GR An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus. Arthritis Rheum 1979 ; 22: 313-320. (Pubitemid 10141614)
13. Bluestein HG, Williams GW, Steinberg AD Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus. In: Am J Med 1981: 240-246.
14. Hanly JG, Rajaraman S., Behmann S., Denburg JA A novel neuronal antigen identified by sera from patients with systemic lupus erythematosus. Arthritis Rheum 1988 ; 31: 1492-1499. (Pubitemid 19028415)
15. Golombek SJ, Graus F., Elkon KB Autoantibodies in the cerebrospinal fluid of patients with systemic lupus erythematosus. Arthritis Rheum 1986 ; 29: 1090-1097. (Pubitemid 16017799)
16. Danon YL, Garty BZ Autoantibodies to neuroblastoma cell surface antigens in neuropsychiatric lupus. Neuropediatrics 1986 ; 17: 23-27.
17. Bluestein HG, Zvaifler NJ Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus. J Clin Invest 1976 ; 57: 509-516.
18. Bonfa E., Golombek SJ, Kaufman LD, et al. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 1987 ; 317: 265-271. (Pubitemid 17100105)
19. Hirohata S., Arinuma Y., Takayama M., Yoshio T. Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus. Arthritis Res Ther 2007 ; 9: R44. (Pubitemid 46852088)
20. Toubi E., Shoenfeld Y. Clinical and biological aspects of anti-P-ribosomal protein autoantibodies. Autoimmun Rev 2007 ; 6: 119-125. (Pubitemid 46201956)
21. Matus S., Burgos PV, Bravo-Zehnder M., et al. Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis. J Exp Med 2007 ; 204: 3221-3234.
22. Kowal C., DeGiorgio LA, Nakaoka T., et al. Cognition and immunity; antibody impairs memory. Immunity 2004 ; 21: 179-188. (Pubitemid 39094048)
23. Kowal C., Degiorgio LA, Lee JY, et al. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci U S A 2006 ; 103: 19854-19859. (Pubitemid 46037520)
24. Emmer BJ, van der Grond J., Steup-Beekman GM, Huizinga TW, van Buchem MA Selective involvement of the amygdala in systemic lupus erythematosus. PLoS Med 2006 ; 3: e499. (Pubitemid 46026446)
25. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001 ; 7: 1189-1193. (Pubitemid 33063773)
26. Arinuma Y., Yanagida T., Hirohata S. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2008 ; 58: 1130-1135. (Pubitemid 351564016)
27. Hanson VG, Horowitz M., Rosenbluth D., Spiera H., Puszkin S. Systemic lupus erythematosus patients with central nervous system involvement show autoantibodies to a 50-kD neuronal membrane protein. J Exp Med 1992 ; 176: 565-573.
28. Isshi K., Hirohata S. Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus. Arthritis Rheum 1998 ; 41: 1819-1827. (Pubitemid 28465536)
29. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982 ; 25: 1271-1277. (Pubitemid 13221242)
30. Okunuki Y., Usui Y., Takeuchi M., et al. Proteomic surveillance of autoimmunity in Behcet's disease with uveitis: selenium binding protein is a novel autoantigen in Behcet's disease. Exp Eye Res 2007 ; 84: 823-831. (Pubitemid 46591966)
31. Katano M., Okamoto K., Arito M., et al. Implication of GM-CSF induced neutrophil gelatinase-associated lipocalin in pathogenesis of rheumatoid arthritis revealed by proteome analysis. Arthritis Res Ther 2009 ; 11: R3.
32. Hoffrogge R., Mikkat S., Scharf C., et al. 2-DE proteome analysis of a proliferating and differentiating human neuronal stem cell line (ReNcell VM). Proteomics 2006 ; 6: 1833-1847.
33. Hirotsu S., Abe Y., Okada K., et al. Crystal structure of a multifunctional 2-Cys peroxiredoxin heme-binding protein 23 kDa/ proliferation-associated gene product. Proc Natl Acad Sci U S A 1999 ; 96: 12333-12338. (Pubitemid 29513502)
34. Csernok E. Anti-neutrophil cytoplasmic antibodies and pathogenesis of small vessel vasculitides. Autoimmun Rev 2003 ; 2: 158-164. (Pubitemid 37443853)
35. Dalpke AH, Thomssen R., Ritter K. Oxidative injury to endothelial cells due to Epstein-Barr virus-induced autoantibodies against manganese superoxide dismutase. J Med Virol 2003 ; 71: 408-416. (Pubitemid 37176631)
36. Huugen D., Tervaert JW, Heeringa P. Antineutrophil cytoplasmic autoantibodies and pathophysiology: new insights from animal models. Curr Opin Rheumatol 2004 ; 16: 4-8. (Pubitemid 38041392)
37. Karasawa R., Ozaki S., Nishioka K., Kato T. Autoantibodies to peroxiredoxin I and IV in patients with systemic autoimmune diseases. Microbiol Immunol 2005 ; 49: 57-65. (Pubitemid 40313120)
38. Okado-Matsumoto A., Matsumoto A., Fujii J., Taniguchi N. Peroxiredoxin IV is a secretable protein with heparin-binding properties under reduced conditions. J Biochem 2000 ; 127: 493-501. (Pubitemid 30185255)
39. Crowley-Weber CL, Payne CM, Gleason-Guzman M., et al. Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate. Carcinogenesis 2002 ; 23: 2063-2080. (Pubitemid 36109121)
40. Jin DY, Chae HZ, Rhee SG, Jeang KT Regulatory role for a novel human thioredoxin peroxidase in NF-kappaB activation. J Biol Chem 1997 ; 272: 30952-30961.
41. Doran JF, Jackson P., Kynoch PA, Thompson RJ Isolation of PGP 9.5, a new human neurone-specific protein detected by high-resolution two-dimensional electrophoresis. J Neurochem 1983 ; 40: 1542-1547. (Pubitemid 13106931)
42. Gong B., Cao Z., Zheng P., et al. Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell 2006 ; 126: 775-788. (Pubitemid 44233627)
43. Sakurai M., Ayukawa K., Setsuie R., et al. Ubiquitin C-terminal hydrolase L1 regulates the morphology of neural progenitor cells and modulates their differentiation. J Cell Sci 2006 ; 119: 162-171. (Pubitemid 43169309)
44. Leroy E., Boyer R., Auburger G., et al. The ubiquitin pathway in Parkinson's disease. Nature 1998 ; 395: 451-452.
45. Setsuie R., Wada K. The functions of UCH-L1 and its relation to neurodegenerative diseases. Neurochem Int 2007 ; 51: 105-111. (Pubitemid 47179898)
46. Kabuta T., Setsuie R., Mitsui T., et al. Aberrant molecular properties shared by familial Parkinson's disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1. Hum Mol Genet 2008 ; 17: 1482-1496. (Pubitemid 351627344)
47. Jumaa H., Nielsen PJ The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation. Embo J 1997 ; 16: 5077-5085. (Pubitemid 27348416)
48. Neugebauer KM, Merrill JT, Wener MH, Lahita RG, Roth MB SR proteins are autoantigens in patients with systemic lupus erythematosus. Arthritis Rheum 2000 ; 43: 1768-1778.
49. Saeki K., Yasugi E., Okuma E., et al. Proteomic analysis on insulin signaling in human hematopoietic cells: identification of CLIC1 and SRp20 as novel downstream effectors of insulin. Am J Physiol Endocrinol Metab 2005 ; 289: E419-428. (Pubitemid 41192697)
50. Monestier M., Kotzin BL Antibodies to histones in systemic lupus erythematosus and drug-induced lupus syndromes. Rheum Dis Clin North Am 1992 ; 18: 415-436.
51. Hardin JA, Thomas JO Antibodies to histones in systemic lupus erythematosus: localization of prominent autoantigens on histones H1 and H2B. Proc Natl Acad Sci U S A 1983 ; 80: 7410-7414. (Pubitemid 14178012)
52. Gioud M., Kaci MA, Monier JC Histone antibodies in systemic lupus erythematosus. A possible diagnostic tool. Arthritis Rheum 1982 ; 25: 407-413. (Pubitemid 12158949)